StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
GNLX

Genelux Corporation

GNLX Nasdaq Pharmaceutical Preparations EDGAR ↗
$2.98
+0.04 +1.36%

Key statistics

from XBRL data in SEC filings
Market cap
$134M
Revenue (TTM)
$8.00K
Net income (TTM)
-$33.6M
EPS (TTM)
$-0.85
P/E ratio
Dividend yield
Free cash flow
-$26.4M
Cash
$9.27M
Total assets
$32.4M
Gross margin
52-week range
$2.29 – $8.54

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results Jun 22, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Entered a material agreement Mar 19, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 8-K Regulation FD disclosure Feb 2, 2026 8-K Other events Jan 8, 2026 8-K Regulation FD disclosure; Other events Jan 5, 2026 8-K Director or officer change Jan 2, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Director or officer change; Shareholder vote results Sep 3, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 29, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Other events Mar 25, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Mar 25, 2025 8-K Director or officer change Feb 3, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Regulation FD disclosure Nov 8, 2024 8-K Director or officer change Oct 3, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Shareholder vote results Aug 6, 2024 8-K Regulation FD disclosure Aug 1, 2024 8-K Regulation FD disclosure; Other events Jun 5, 2024 8-K Entered a material agreement; Regulation FD disclosure; Other events May 24, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Regulation FD disclosure Apr 9, 2024 8-K Regulation FD disclosure Apr 2, 2024 10-K Fiscal year ended 2023-12-31 Mar 29, 2024 8-K Regulation FD disclosure Feb 5, 2024 8-K Results of operations (earnings release); Other events Feb 2, 2024 8-K Regulation FD disclosure Dec 12, 2023 8-K Director or officer change Nov 24, 2023 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Regulation FD disclosure Oct 10, 2023 8-K Director or officer change; Shareholder vote results Sep 14, 2023 8-K Director or officer change Aug 28, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 8-K Regulation FD disclosure; Other events Jul 19, 2023 8-K Delisting notice or listing-rule failure; Director or officer change Jul 14, 2023